EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 94 filers reported holding EPIZYME INC in Q4 2016. The put-call ratio across all filers is 3.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $17,044,000 | +41.4% | 960,200 | 0.0% | 0.01% | +50.0% |
| Q4 2017 | $12,051,000 | -38.9% | 960,200 | -7.2% | 0.01% | -40.0% |
| Q3 2017 | $19,719,000 | +26.2% | 1,035,100 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $15,630,000 | -21.6% | 1,035,100 | -11.0% | 0.01% | -20.0% |
| Q1 2017 | $19,945,000 | +41.7% | 1,163,000 | 0.0% | 0.01% | +42.9% |
| Q4 2016 | $14,072,000 | +19.2% | 1,163,000 | -3.1% | 0.01% | +16.7% |
| Q3 2016 | $11,808,000 | -3.9% | 1,200,000 | 0.0% | 0.01% | -14.3% |
| Q2 2016 | $12,288,000 | -15.5% | 1,200,000 | 0.0% | 0.01% | -12.5% |
| Q1 2016 | $14,544,000 | +3.5% | 1,200,000 | +242.9% | 0.01% | +14.3% |
| Q3 2013 | $14,046,000 | +41.0% | 350,000 | -1.2% | 0.01% | +16.7% |
| Q2 2013 | $9,961,000 | – | 354,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |